Table 5. The clinicopathological characteristic of the 255 patients enrolled in the study.
| Patient characteristic | Number of patients (%) |
|---|---|
| Sex | |
| Male | 186 (72.9%) |
| Female | 69 (27.1%) |
| Age (years) | |
| Median (range) | 52 |
| ≥ 60 | 66 (25.9%) |
| < 60 | 189 (74.1%) |
| WHO histologic type | |
| II | 5 (2%) |
| III | 244 (95.7%) |
| Other | 6 (2.3%) |
| T stage | |
| T1 | 39 (15.3%) |
| T2 | 65 (25.5%) |
| T3 | 84 (32.9%) |
| T4 | 67 (26.3%) |
| N stage | |
| N0 | 18 (7.1%) |
| N1 | 74 (29%) |
| N2 | 117 (45.9%) |
| N3 | 46 (18%) |
| UICC stage | |
| I | 2 (7.8%) |
| II | 34 (13.3%) |
| III | 119 (46.7%) |
| IV | 10039.2%) |
| Combined chemotherapy | |
| Yes | 231 (90.6%) |
| No | 24 (9.4%) |